Impact of obstructive sleep apnea on the 24-h metabolic hormone profile

Sleep Medicine

Volumn 15, Issue 6, 2014, Pages 625-630

  Sanchez de la Torre M ^a,d   Barcelo A ^b,d   Pierola J ^b   de la Pena M ^b,d   Valls, J ^c   Barbe F ^a,d  

^a UNIVERSITY OF LLEIDA   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^c UNIVERSITY OF LLEIDA   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Circadian rhythms; Day night variations; Metabolic hormones; Metabolism; OSA; Sleep apnea

Indexed keywords

ADIPONECTIN; GHRELIN; LEPTIN; RESISTIN; GASTROINTESTINAL HORMONE;

ADULT; APNEA HYPOPNEA INDEX; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE RESPONSE; HUMAN; MALE; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; BLOOD; CASE CONTROL STUDY; COMPLICATION; METABOLIC DISEASES; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADIPONECTIN; ADULT; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; ENZYME-LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL HORMONES; GHRELIN; HUMANS; LEPTIN; MALE; METABOLIC DISEASES; RESISTIN; SLEEP APNEA, OBSTRUCTIVE;

EID: 84901604663     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2014.03.007     Document Type: Article

References (33)

1. Duran J., Esnaola S., Rubio R., Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30-70years. Am J Respir Crit Care Med 2001, 163:685-689.
2. Punjabi N.M. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 2008, 5:136-143.
3. Sánchez-de-la-Torre M., Campos-Rodriguez F., Barbé F. Obstructive sleep apnoea and cardiovascular disease. Lancet Respir Med 2013, 1:61-72.
4. Young T., Peppard P.E., Taheri S. Excess weight and sleep-disordered breathing. J Appl Physiol 2005, 99:1592-1599.
5. Li C., Ford E.S., Zhao G., Croft J.B., Balluz L.S., Mokdad A.H. Prevalence of self-reported clinically diagnosed sleep apnea according to obesity status in men and women: National Health and Nutrition Examination Survey, 2005-2006. Prev Med 2010, 51:18-23.
6. Sánchez-de-la-Torre M., Mediano O., Barceló A., Pierola J., Peña M., Esquinas C., et al. The influence of obesity and obstructive sleep apnea on metabolic hormones. Sleep Breath 2011, 16:649-656.
7. Barceló A., Barbé F., Llompart E., La Peña de M., Durán-Cantolla J., Ladaria A., et al. Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity. Am J Respir Crit Care Med 2005, 171:183-187.
8. Phillips B.G., Kato M., Narkiewicz K., Choe I., Somers V.K. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 2000, 279:H234-H237.
9. Ursavaş A., Ilcol Y.O., Nalci N., Karadag M., Ege E. Ghrelin, leptin, adiponectin, and resistin levels in sleep apnea syndrome: role of obesity. Ann Thorac Med 2010, 5:161-165.
10. Arnardottir E.S., Mackiewicz M., Gislason T., Teff K.L., Pack A.I. Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep 2009, 32:447-470.
11. Bray M.S., Young M.E. Circadian rhythms in the development of obesity: potential role for the circadian clock within the adipocyte. Obes Rev 2007, 8:169-181.
12. Barceló A., Piérola J., La Peña de M., Esquinas C., Sánchez-de-la-Torre M., Ayllon O., et al. Day-night variations in endothelial dysfunction markers and haemostatic factors in sleep apnoea. Eur Respir J 2012, 39:913-918.
13. Patel S.R., Palmer L.J., Larkin E.K., Jenny N.S., White D.P., Redline S. Relationship between obstructive sleep apnea and diurnal leptin rhythms. Sleep 2004, 27:235-239.
14. Motivala S.J., Tomiyama A.J., Ziegler M., Khandrika S., Irwin M.R. Nocturnal levels of ghrelin and leptin and sleep in chronic insomnia. Psychoneuroendocrinology 2009, 34:540-545.
15. Yildiz B.O., Suchard M.A., Wong M.-L., McCann S.M., Licinio J. Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. Proc Natl Acad Sci U S A 2004, 101:10434-10439.
16. Matthews J.N., Altman D.G., Campbell M.J., Royston P. Analysis of serial measurements in medical research. BMJ 1990, 300:230-235.
17. Gnacińska M., Małgorzewicz S., Stojek M., Lysiak-Szydłowska W., Sworczak K. Role of adipokines in complications related to obesity. A review. Adv Med Sci 2009, 1-8.
18. Wallace A.M., McMahon A.D., Packard C.J., Kelly A., Shepherd J., Gaw A., et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001, 104:3052-3056.
19. Soderberg S., Ahrén B., Jansson J.H., Johnson O., Hallmans G., Asplund K., et al. Leptin is associated with increased risk of myocardial infarction. J Intern Med 1999, 246:409-418.
20. Schäfer H., Pauleit D., Sudhop T., Gouni-Berthold I., Ewig S., Berthold H.K. Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 2002, 122:829-839.
21. Manzella D., Parillo M., Razzino T., Gnasso P., Buonanno S., Gargiulo A., et al. Soluble leptin receptor and insulin resistance as determinant of sleep apnea. Int J Obes Relat Metab Disord 2002, 26:370-375.
22. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7:941-946.
23. Funahashi T., Nakamura T., Shimomura I., Maeda K., Kuriyama H., Takahashi M., et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 1999, 38:202-206.
24. Berg A.H., Combs T.P., Scherer P.E. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002, 13:84-89.
25. Zhang X.-L., Yin K.-S., Wang H., Su S. Serum adiponectin levels in adult male patients with obstructive sleep apnea hypopnea syndrome. Respiration 2006, 73:73-77.
26. Wolk R., Svatikova A., Nelson C.A., Gami A.S., Govender K., Winnicki M., et al. Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea. Obes Res 2005, 13:186-190.
27. Lam J.C.M., Xu A., Tam S., Khong P.-I., Yao T.-J., Lam D.C.L., et al. Hypoadiponectinemia is related to sympathetic activation and severity of obstructive sleep apnea. Sleep 2008, 31:1721-1727.
28. Tokuda F., Sando Y., Matsui H., Koike H., Yokoyama T. Serum levels of adipocytokines, adiponectin and leptin, in patients with obstructive sleep apnea syndrome. Intern Med 2008, 47:1843-1849.
29. Hargens T.A., Guill S.G., Kaleth A.S., Nickols-Richardson S.M., Miller L.E., Zedalis D., et al. Insulin resistance and adipose-derived hormones in young men with untreated obstructive sleep apnea. Sleep Breath 2013, 17:403-409.
30. Nakagawa Y., Kishida K., Kihara S., Sonoda M., Hirata A., Yasui A., et al. Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome. Am J Physiol Endocrinol Metab 2008, 294:E778-E784.
31. Ulukavak Ciftci T., Kokturk O., Bukan N., Bilgihan A. Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome. Respiration 2005, 72:395-401.
32. Yamamoto Y., Fujiuchi S., Hiramatsu M., Nishigaki Y., Takeda A., Fujita Y., et al. Resistin is closely related to systemic inflammation in obstructive sleep apnea. Respiration 2008, 76:377-385.
33. Wysocka E., Cofta S., Dziegielewska S., Gozdzik J., Torlinski L., Batura-Gabryel H. Adipocytokines in sleep apnea syndrome. Eur J Med Res 2009, 14(Suppl. 4):255-258.